{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T03:53:35Z","timestamp":1786334015624,"version":"build-2736575974"},"reference-count":76,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.clml.2017.07.008","type":"journal-article","created":{"date-parts":[[2017,7,23]],"date-time":"2017-07-23T02:15:12Z","timestamp":1500776112000},"page":"863-869","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["The Clinical Spectrum of Hepatic Manifestations in Chronic Lymphocytic Leukemia"],"prefix":"10.1016","volume":"17","author":[{"given":"Natalia","family":"Kreiniz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofrat","family":"Beyar Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Polliack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamar","family":"Tadmor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2017.07.008_bib1","first-page":"3","article-title":"The haematology of liver disease","volume":"3","author":"Chisholm","year":"1981","journal-title":"Acta Med Port"},{"key":"10.1016\/j.clml.2017.07.008_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/484903","article-title":"Hepatic manifestations in hematological disorders","volume":"2013","author":"Murakami","year":"2013","journal-title":"Int J Hepatol"},{"key":"10.1016\/j.clml.2017.07.008_bib3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1148\/rg.351130008","article-title":"Hematologic malignancies of the liver: spectrum of disease","volume":"35","author":"Tomasian","year":"2015","journal-title":"Radiographics"},{"key":"10.1016\/j.clml.2017.07.008_bib4","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1365-2141.2006.06465.x","article-title":"Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies","volume":"136","author":"Lalazar","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2017.07.008_bib5","doi-asserted-by":"crossref","first-page":"474","DOI":"10.4149\/neo_2017_320","article-title":"Infectious complications in chronic lymphocytic leukemia-a retrospective analysis: single institution experience","volume":"64","author":"Demitrovicova","year":"2017","journal-title":"Neoplasma"},{"key":"10.1016\/j.clml.2017.07.008_bib6","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S1470-2045(16)30051-1","article-title":"First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trial","volume":"17","author":"Eichhorst","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clml.2017.07.008_bib7","series-title":"Holland-Frei Manual of Cancer Medicine 8","first-page":"1604","article-title":"Chronic lymphocytic leukemia","author":"Hong","year":"2010"},{"key":"10.1016\/j.clml.2017.07.008_bib8","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1200\/JCO.1987.5.3.398","article-title":"Prognosis in chronic lymphocytic leukemia: a retrospective multicentric study from the GIMEMA group","volume":"5","author":"Mandelli","year":"1987","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2017.07.008_bib9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1590\/S1516-31802000000400002","article-title":"Prognosis related to staging systems for chronic lymphocytic leukemia","volume":"118","author":"de Faria","year":"2000","journal-title":"Sao Paulo Med J"},{"key":"10.1016\/j.clml.2017.07.008_bib10","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1182\/blood.V98.1.181","article-title":"CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia","volume":"98","author":"Ibrahim","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.clml.2017.07.008_bib11","first-page":"197","article-title":"Clinical presentation and outcome of Thai patients with chronic lymphocytic leukemia: retrospective analysis of 184 cases","volume":"23","author":"Sriphatphiriyakun","year":"2005","journal-title":"Asian Pac J Allergy Immunol"},{"key":"10.1016\/j.clml.2017.07.008_bib12","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1200\/JCO.2008.17.5398","article-title":"Other malignancies in chronic lymphocytic leukemia\/small lymphocytic lymphoma","volume":"27","author":"Tsimberidou","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2017.07.008_bib13","first-page":"187","article-title":"Chronic lymphocytic leukaemia: a-twenty-years experience and problems in Ile-Ife, South-Western Nigeria","volume":"10","author":"Salawu","year":"2010","journal-title":"Afr Health Sci"},{"key":"10.1016\/j.clml.2017.07.008_bib14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jnci.2011.07.002","article-title":"Study of fibromodulin gene expression in B-cell chronic lymphocytic leukemia","volume":"23","author":"Hassan","year":"2011","journal-title":"J\u00a0Egypt Natl Canc Inst"},{"key":"10.1016\/j.clml.2017.07.008_bib15","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.3109\/10428194.2012.672734","article-title":"Assessment of 285 cases of chronic lymphocytic leukemia seen at single large tertiary center in Northern India","volume":"53","author":"Gogia","year":"2012","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2017.07.008_bib16","doi-asserted-by":"crossref","first-page":"215","DOI":"10.7314\/APJCP.2016.17.1.215","article-title":"Watch and wait in Lebanese chronic lymphocytic leukemia patients: how relevant is it?","volume":"17","author":"Lutfallah","year":"2016","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.clml.2017.07.008_bib17","article-title":"Liver dysfunction in previously untreated chronic lymphocytic leukemia: prevalence and outcomes in a large cohort","author":"Hampel","year":"2016","journal-title":"Am Soc Hematology"},{"key":"10.1016\/j.clml.2017.07.008_bib18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2559.2008.03069.x","article-title":"Patterns of liver infiltration in lymphoproliferative disease","volume":"53","author":"Baumhoer","year":"2008","journal-title":"Histopathology"},{"key":"10.1016\/j.clml.2017.07.008_bib19","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0046-8177(81)80023-8","article-title":"The effects of leukemic infiltrates in various organs in chronic lymphocytic leukemia","volume":"12","author":"Schwartz","year":"1981","journal-title":"Hum Pathol"},{"key":"10.1016\/j.clml.2017.07.008_bib20","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1155\/2011\/176836","article-title":"Chronic lymphocytic leukemia-associated cholangiopathy","volume":"25","author":"Mann","year":"2011","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.clml.2017.07.008_bib21","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/0002-9343(86)90033-1","article-title":"Hepatorenal syndrome complicating chronic lymphocytic leukemia","volume":"80","author":"Papadakis","year":"1986","journal-title":"Am J Med"},{"key":"10.1016\/j.clml.2017.07.008_bib22","first-page":"28","article-title":"Chronic lymphocytic leukemia presenting as jaundice","volume":"17","author":"Pandey","year":"1998","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.clml.2017.07.008_bib23","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/RLU.0b013e3181e4dcad","article-title":"Hepatic superscan on PET\/CT due to Richter\u2019s transformation of chronic lymphocytic leukemia","volume":"35","author":"Taneja","year":"2010","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.clml.2017.07.008_bib24","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.4081\/rt.2012.e51","article-title":"A\u00a0case of chronic lymphocytic leukemia with massive ascites","volume":"4","author":"Yonal","year":"2012","journal-title":"Rare Tumors"},{"key":"10.1016\/j.clml.2017.07.008_bib25","first-page":"593","article-title":"Chronic lymphocytic leukemia presenting with massive chylous ascites","volume":"85","author":"Davis","year":"1990","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clml.2017.07.008_bib26","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1182\/asheducation-2008.1.450","article-title":"Disease-specific complications of chronic lymphocytic leukemia","volume":"2008","author":"Dearden","year":"2008","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.clml.2017.07.008_bib27","first-page":"730131","article-title":"Autoimmune cytopenias in chronic lymphocytic leukemia","volume":"2013","author":"D\u2019Arena","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.clml.2017.07.008_bib28","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.clml.2011.02.005","article-title":"Unusual autoimmune nonhematologic complications in chronic lymphocytic leukemia","volume":"11","author":"Jung","year":"2011","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.clml.2017.07.008_bib29","series-title":"Liver pathology","first-page":"36","article-title":"Syncytial giant cell hepatitis","author":"Ferrell","year":"2011"},{"key":"10.1016\/j.clml.2017.07.008_bib30","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2326-12-8","article-title":"Syncytial giant cell hepatitis associated with chronic lymphocytic leukemia: a case report","volume":"12","author":"Gupta","year":"2012","journal-title":"BMC Blood Disord"},{"key":"10.1016\/j.clml.2017.07.008_bib31","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1111\/j.1572-0241.1998.00548.x","article-title":"A\u00a0case of syncytial giant cell hepatitis with features of a paramyxoviral infection","volume":"93","author":"Fimmel","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clml.2017.07.008_bib32","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/01.meg.0000050026.34359.7c","article-title":"A\u00a0fatal case of postinfantile giant cell hepatitis in a patient with chronic lymphocytic leukaemia","volume":"15","author":"Alexopoulou","year":"2003","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.clml.2017.07.008_bib33","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/0168-8278(92)90039-R","article-title":"Syncytial giant-cell hepatitis\u2014a specific disease entity?","volume":"15","author":"Lau","year":"1992","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clml.2017.07.008_bib34","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/bjh.13196","article-title":"Clinico-biological characteristics and treatment of type I monoclonal cryoglobulinaemia: a study of 64 cases","volume":"168","author":"Harel","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2017.07.008_bib35","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3816\/CLM.2005.n.012","article-title":"Clinical characteristics and outcome of immunoglobulin M\u2013related disorders","volume":"5","author":"Cesana","year":"2005","journal-title":"Clin Lymphoma"},{"key":"10.1016\/j.clml.2017.07.008_bib36","doi-asserted-by":"crossref","first-page":"5841","DOI":"10.1200\/JCO.2005.07.004","article-title":"Unusual leukemia presentations: case 3. Type I IgG\u03bb cryoglobulinemia associated with chronic lymphocytic leukemia","volume":"23","author":"Mantha","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2017.07.008_bib37","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/1097-0142(194903)2:2<319::AID-CNCR2820020210>3.0.CO;2-F","article-title":"Cryoglobulinemia and Raynaud\u2019s syndrome in a case of chronic lymphocytic leukemia","volume":"2","author":"Schwartz","year":"1949","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2017.07.008_bib38","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.bcmd.2016.05.009","article-title":"Cryoglobulinemia in a patient with chronic lymphocytic leukemia\u2014A case report and review of literature of renal involvement in CLL","volume":"60","author":"Arora","year":"2016","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.clml.2017.07.008_bib39","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.cvsm.2016.11.010","article-title":"Acute liver injury and failure","volume":"47","author":"Thawley","year":"2017","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"10.1016\/j.clml.2017.07.008_bib40","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1136\/gut.42.4.576","article-title":"Acute liver failure secondary to hepatic infiltration: a single centre experience of 18 cases","volume":"42","author":"Rowbotham","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.clml.2017.07.008_bib41","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3747\/co.v18i1.756","article-title":"Acute liver failure because of chronic lymphocytic leukemia: case report and review of the literature","volume":"18","author":"Esfahani","year":"2011","journal-title":"Curr Oncol"},{"key":"10.1016\/j.clml.2017.07.008_bib42","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1023\/A:1018889904839","article-title":"Case report: acute liver failure due to hepatic involvement by hematologic malignancy","volume":"42","author":"Shehab","year":"1997","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clml.2017.07.008_bib43","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/mpo.2950160514","article-title":"T4+ (helper phenotype) chronic lymphocytic leukemia: case report with liver failure and literature review","volume":"16","author":"Greer","year":"1988","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.clml.2017.07.008_bib44","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3109\/10428199809057552","article-title":"Hepatic outflow obstruction and liver failure due to leukemic cell infiltration in chronic lymphocytic leukemia","volume":"30","author":"Costa","year":"1998","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2017.07.008_bib45","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2165\/00003495-197816010-00002","article-title":"Drug-induced liver disease","volume":"16","author":"Zimmerman","year":"1978","journal-title":"Drugs"},{"key":"10.1016\/j.clml.2017.07.008_bib46","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1513257","article-title":"Targeting BCL2 with venetoclax in relapsed chronic lymphocytic leukemia","volume":"374","author":"Roberts","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clml.2017.07.008_bib47","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1215637","article-title":"Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia","volume":"369","author":"Byrd","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clml.2017.07.008_bib48","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1182\/blood-2013-11-535047","article-title":"Idelalisib, an inhibitor of phosphatidylinositol 3-kinase p110\u03b4, for relapsed\/refractory chronic lymphocytic leukemia","volume":"123","author":"Brown","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.clml.2017.07.008_bib49","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1053\/j.seminoncol.2005.11.002","article-title":"Hepatotoxicity of chemotherapy","volume":"33","author":"Floyd","year":"2006","journal-title":"Sem Oncol"},{"key":"10.1016\/j.clml.2017.07.008_bib51","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/hep.26175","article-title":"LiverTox: a website on drug-induced liver injury","volume":"57","author":"Hoofnagle","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.clml.2017.07.008_bib52","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1093\/annonc\/mdq583","article-title":"Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports","volume":"22","author":"Evens","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clml.2017.07.008_bib53","first-page":"143","article-title":"Hepatitis B reactivation with novel agents in non-Hodgkin's lymphoma and prevention strategies","volume":"4","author":"Ozoya","year":"2016","journal-title":"J\u00a0Clin Transl Hepatol"},{"key":"10.1016\/j.clml.2017.07.008_bib54","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1600-0609.2004.00375.x","article-title":"Hepatitis B virus reactivation and alemtuzumab therapy","volume":"74","author":"Iannitto","year":"2005","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.clml.2017.07.008_bib55","doi-asserted-by":"crossref","first-page":"6484","DOI":"10.3748\/wjg.v22.i28.6484","article-title":"Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies treated with anticancer therapy","volume":"22","author":"Law","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clml.2017.07.008_bib56","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3109\/10428194.2015.1071489","article-title":"Chronic lymphocytic leukemia, autoimmune hemolytic anemia and ibrutinib: a case report and review of the literature","volume":"57","author":"Molica","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2017.07.008_bib57","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00277-016-2917-2","article-title":"Severe hepatitis B virus reactivation related to ibrutinib monotherapy","volume":"96","author":"Herishanu","year":"2017","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clml.2017.07.008_bib58","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1007\/s40265-014-0285-6","article-title":"Idelalisib: first global approval","volume":"74","author":"Markham","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.clml.2017.07.008_bib59","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa1315226","article-title":"Idelalisib and rituximab in relapsed chronic lymphocytic leukemia","volume":"370","author":"Furman","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clml.2017.07.008_bib60","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1182\/blood-2016-03-707133","article-title":"Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity","volume":"128","author":"Lampson","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.clml.2017.07.008_bib61","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.3109\/10428194.2015.1022770","article-title":"Management of adverse events associated with idelalisib treatment: expert panel opinion","volume":"56","author":"Coutr\u00e9","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2017.07.008_bib62","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1093\/jnci\/84.18.1422","article-title":"Second cancers in patients with chronic lymphocytic leukemia","volume":"84","author":"Travis","year":"1992","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clml.2017.07.008_bib63","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1080\/10428190310001612939","article-title":"Veterans with chronic lymphocytic leukemia\/small lymphocytic lymphoma (CLL\/SLL) have a markedly increased rate of second malignancy, which is the most common cause of death","volume":"45","author":"Kyasa","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2017.07.008_bib64","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/10428190400007524","article-title":"Second neoplasms in chronic lymphocytic leukemia: incidence and pathogenesis with emphasis on the role of different therapies","volume":"46","author":"Molica","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2017.07.008_bib65","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1159\/000227383","article-title":"Extrahepatic primary malignant neoplasms associated with hepatocellular carcinoma: high occurrence of B cell tumors","volume":"51","author":"Di Stasi","year":"1994","journal-title":"Oncology"},{"key":"10.1016\/j.clml.2017.07.008_bib66","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000268853","article-title":"Concurrent and apposed hepatocellular carcinoma and small lymphocytic lymphoma\/chronic lymphocytic leukemia in a patient with hepatitis C virus","volume":"123","author":"Becker","year":"2010","journal-title":"Acta Haematol"},{"key":"10.1016\/j.clml.2017.07.008_bib67","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3109\/10428199609052438","article-title":"Merkel cell tumor in a woman with chronic lymphocytic leukemia","volume":"20","author":"Safadi","year":"1996","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2017.07.008_bib68","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1053\/j.seminoncol.2016.02.012","article-title":"Richter syndrome: pathogenesis and management","volume":"43","author":"Rossi","year":"2016","journal-title":"Sem Oncol"},{"key":"10.1016\/j.clml.2017.07.008_bib69","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1182\/blood-2013-11-516229","article-title":"How we treat Richter syndrome","volume":"123","author":"Parikh","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.clml.2017.07.008_bib70","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1365-2141.2011.08734.x","article-title":"Richter syndrome in chronic lymphocytic leukaemia manifesting only as tumorous hepatomegaly","volume":"155","author":"Tadmor","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2017.07.008_bib71","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1016\/j.transproceed.2012.12.001","article-title":"An unusual presentation of a chronic lymphocytic leukemia patient with 17p deletion after reduced-intensity transplantation: Richter syndrome and concomitant graft-versus-host disease\u2014case report","volume":"45","author":"Salihoglu","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1016\/j.clml.2017.07.008_bib72","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/ajh.23939","article-title":"Hodgkin transformation of chronic lymphocytic leukemia: Incidence, outcomes, and comparison to de novo Hodgkin lymphoma","volume":"90","author":"Parikh","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2017.07.008_bib73","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s00247-017-3779-z","article-title":"Gaucher disease in the liver on hepatocyte specific contrast agent enhanced MR imaging","volume":"47","author":"Ayyala","year":"2017","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.clml.2017.07.008_bib74","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/1097-0142(19840715)54:2<312::AID-CNCR2820540222>3.0.CO;2-I","article-title":"Gaucher\u2019s disease and chronic lymphocytic leukemia. Possible pathogenetic link between Gaucher\u2019s disease and B-cell proliferations?","volume":"54","author":"Fox","year":"1984","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2017.07.008_bib75","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S0002-9270(00)02425-4","article-title":"Hepatic manifestations of hemophagocytic syndrome: a study of 30 cases","volume":"96","author":"De Kerguenec","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clml.2017.07.008_bib76","doi-asserted-by":"crossref","first-page":"287","DOI":"10.4065\/77.3.287","article-title":"Hemophagocytosis in a patient with chronic lymphocytic leukemia and histoplasmosis","volume":"77","author":"Rao","year":"2002","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.clml.2017.07.008_bib77","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/bjh.12468","article-title":"Disseminated histoplasmosis diagnosed by peripheral blood film in a patient with chronic lymphocytic leukaemia","volume":"162","author":"Xu","year":"2013","journal-title":"Br J Haematol"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265017309606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265017309606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:31:25Z","timestamp":1761870685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265017309606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":76,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S2152265017309606"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2017.07.008","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Clinical Spectrum of Hepatic Manifestations in Chronic Lymphocytic Leukemia","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2017.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}